Guidelines

O.5 BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and meta-analysis on the risk of cardiovascular events, major molecular response and overall survival

January 2016
O.6 Effect of bone marrow-mesenchymal stromal cell derived extracellular vesicles on survival, migration and chemoresistance of Chronic Lymphocytic Leukemia B-cells

January 2016
PP1.1 Evaluation of Next Generation Sequencing based clonality analysis of TRG gene rearrangements

January 2016
PP1.2 The immunosuppressive role of the adipokine leptin in multiple myeloma

January 2016
PP1.3 Galectin-1 is involved in osteoclast biology

January 2016
PP1.5 Epigenetics in chronic lymphocytic leukemia: significance of TET and IDH enzymes expression on prognosis and influence of microenvironment

January 2016
PP2.1 Immunomodulatory effects of rapamycin in Graft versus Host Disease

January 2016
PP2.2 Treatment of essential thrombocythemia in Europe: an observational study of 3649 high-risk patients in EXELS

January 2016
PP2.3 A novel FGA mutation underlying a case of congenital dysfibrinogenemia with unusual clinical presentation

January 2016
PP2.4 Identifying infectious triggering factors even in the presence of known predisposing diseases is mandatory in hemophagocytic lymphohistiocytosis, a review of 35 cases in two Belgian hospitals

January 2016

Top